camrelizumab

E1995667 UNEXPLORED

Camrelizumab is a humanized monoclonal antibody immune checkpoint inhibitor used in cancer therapy to enhance antitumor immune responses.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label Occurrences
camrelizumab canonical 2

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

programmed cell death protein 1 → targetOfDrug → camrelizumab ⓘ
PD-1 → isTargetOfDrug → camrelizumab ⓘ